Holen Sie sich die Stockscreener-App
1.70
1.19%
0.02
Schlusskurs vom Vortag:
$1.68
Offen:
$1.72
24-Stunden-Volumen:
259.98K
Relative Volume:
0.76
Marktkapitalisierung:
$114.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-64.20M
KGV:
-0.7907
EPS:
-2.15
Netto-Cashflow:
$57,000
1W Leistung:
+17.24%
1M Leistung:
+34.92%
6M Leistung:
+1.19%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.66
$1.749
1-Wochen-Bereich:
$1.63
$1.85
52-Wochen-Spanne:
$1.05
$5.47
Climb Bio Inc Stock (CLYM) Company Profile
Firmenname
Climb Bio Inc
Sektor
Branche
Telefon
1-866-857-2596
Adresse
20 WILLIAM STREET, WELLESLEY HILLS
Vergleichen Sie CLYM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CLYM
Climb Bio Inc
|
1.70 | 118.26M | 0 | -64.20M | 57,000 | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Climb Bio Inc Stock (CLYM) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-06 | Eingeleitet | Oppenheimer | Outperform |
| 2025-05-22 | Eingeleitet | BTIG Research | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
Climb Bio Inc Aktie (CLYM) Neueste Nachrichten
News impact scoring models applied to Astera Labs Inc.Portfolio Allocation Strategy for Stability - Newser
Will Advent Technologies Holdings Inc. Equity Warrant stock recover after recent dropSmart Swing Picks with Confirmed Signals - Newser
Technical analysis overview for Zoomcar Holdings Inc. stockSmart Trend Analysis With Buy Point Cues - Newser
Using RSI to spot recovery in i3 Verticals Inc.Entry Opportunity Screener with Confirmation - Newser
Is a relief rally coming for Climb Bio Inc. holdersFree Top Gaining Picks With Entry Signals - Newser
Will Climb Bio Inc. outperform the marketGrowth Summary Based on Market Positioning - Newser
Is it too late to sell Climb Bio Inc.Daily Exit and Entry Price Prediction - Newser
Trend analysis for ESS Tech Inc. Equity Warrant this weekReal Time Trade Execution Alert Plan - Newser
Exit strategy if you’re trapped in Climb Bio Inc.Free Buy Low Sell High Stock Watch - Newser
Climb Bio Inc. stock daily chart insightsRapid Trade Forecast Based on Indicators - Newser
Advanced analytics toolkit walkthrough for PennantPark Floating Rate Capital Ltd.Free Breakout Confirmation With Entry Tracker - Newser
How to recover losses in Urgent.ly Inc. stockEarly Entry Ideas with Momentum Potential - Newser
Historical volatility pattern of Climb Bio Inc. visualizedRisk Balanced Picks for Safer Trading - Newser
Short interest data insights for Citizens Inc.Buy Candidate Summary Based on Fundamentals - Newser
Volume spikes in Climb Bio Inc. stock – what they meanTechnical Reversal Setup with Risk Limits - Newser
Is it too late to sell CYCNLong-Term Safety Investment Analysis Report - Newser
How to use Fibonacci retracement on Brenmiller Energy LtdDaily Equity Signal Strength Summary Report - Newser
Understanding PTGX’s price movementFree Stock Market Entry Timing Signals - Newser
How to forecast Weyco Group Inc. trends using time seriesFree Real-Time Market Sentiment Tracking Tool - Newser
Market reaction to The9 Limited Depositary Receipt’s recent newsForecasting Stock Moves with AI Insights - Newser
Predicting Equity Bancshares Inc. trend using moving averagesGrowth Projection Summary for Long-Term Investors - Newser
Using data models to predict Climb Bio Inc. stock movementRisk-Managed Trade Alerts for Consistency - Newser
Market reaction to Climb Bio Inc.’s recent newsExpert-Backed High Yield Stock Watchlist - Newser
64,914 Shares in Climb Bio, Inc. (NASDAQ:CLYM) Bought by Bank of New York Mellon Corp - Defense World
What makes Climb Bio Inc. stock price move sharplyTen-Year Sector Performance and Summary Analysis - Newser
Climb Bio, Inc. shares fall 2.30% intraday as Fujifilm reports mixed Q1 results. - AInvest
TD Asset Management Inc Buys Shares of 89,400 Climb Bio, Inc. (NASDAQ:CLYM) - Defense World
Will Climb Bio Inc. stock recover after recent dropFree Weekly Watchlist of High Movers - Newser
Using Python tools to backtest Climb Bio Inc. strategiesFree ROI Boosting Trade Opportunity Calendar - Newser
Signal strength of Achieve Life Sciences Inc. stock in tech scannersWeekly Signal Report with Trend Summary - Newser
Using fundamentals and technicals on Republic Bancorp Inc.Free Daily Chart Pattern Stock Forecast - Newser
Building trade automation scripts for Climb Bio Inc.Daily Market Movers Screener with Filters - Newser
Climb Bio Inc. Company Revenue and Profit Trends: A Deep DiveSwing Entry Risk Mitigation with Chart Analysis - Newser
Applying Elliott Wave Theory to Under Armour Inc.Oversold Reversal Picks with Buy Zone - Newser
How Resilient Is Aclaris Therapeutics Inc. Stock During Economic DownturnsDaily Trade Monitor with Pattern Alerts - Newser
How to escape a deep drawdown in Tectonic Financial Inc.Buy Candidate Summary Based on Fundamentals - Newser
Climb Bio Inc (CLYM) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Climb Bio (CLYM.O) Surges 17%: Technical Signal, Order-Flow, and Sector Clues Unveiled - AInvest
Climb Bio (CLYM.O) Surges 17%: A Deep-Dive Into the Technical and Market Forces Behind the Move - AInvest
What is the dividend policy of Climb Bio Inc. stockDynamic profit opportunities - Jammu Links News
Using RSI to spot recovery in Ontrak Inc.Weekly Gain Forecast with Momentum Indicators - Newser
Is UPSD stock reversal real or fakeBuy Strategy Review With Performance Summary - Newser
How does Climb Bio Inc. generate profit in a changing economyGet daily expert analysis on top stocks - Jammu Links News
Why Climb Bio Inc. stock attracts strong analyst attentionFree Weekly Hot Picks With Buy Confidence - Newser
What are the latest earnings results for Climb Bio Inc.Unstoppable investment returns - Jammu Links News
When is Climb Bio Inc. stock expected to show significant growthDouble-digit growth - Jammu Links News
What drives Climb Bio Inc. stock priceGame-changing capital returns - Jammu Links News
Kalyani Forge Limited (513509) Stock RalliesSuperior investment outcomes - Jammu Links News
Is it the right time to buy Climb Bio Inc. stockTrack stocks with high upside potential easily - Jammu Links News
Should I hold or sell Climb Bio Inc. stock in 2025Build a portfolio that grows with the market - Jammu Links News
Finanzdaten der Climb Bio Inc-Aktie (CLYM)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):